NOVOZYMES A/S: Financial statements 2021
CVR: 10007127
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
NOVOZYMES A/S (CVR 10007127) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 14,951,000,000 and a net result of DKK 3,145,000,000 compared with DKK 2,826,000,000 the year before. That is an increase of 6.7% compared with the year before. The profit margin was 21%. Equity in the 2021 report amounted to DKK 12,206,000,000. The solvency ratio was 49.3%. The company had 6,240 employees in the financial year.
- Revenue
- DKK 14,951,000,000
- Gross Profit
- DKK 8,623,000,000
- Profit/Loss
- DKK 3,145,000,000
- Equity
- DKK 12,206,000,000
- Total Assets
- DKK 24,767,000,000
- Employees
- 6,240
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 15B | 8.6B | 3.1B | 12.2B | 6240 |
| 2020 | 14B | 7.9B | 2.8B | 11.2B | 6099 |
| 2019 | 14.4B | 8B | 3.2B | 11.5B | - |
| 2018 | 14.4B | 8.3B | 3.2B | 11.4B | - |
| 2017 | 14.5B | 8.4B | 3.1B | 11.3B | - |
Official annual report
Find more companies like NOVOZYMES A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
NOVOZYMES A/S has published its interim report for the period January 1, 2021 to September 30, 2021.
NOVOZYMES A/S has published its interim report for the period January 1, 2021 to June 30, 2021.
NOVOZYMES A/S has published its interim report for the period January 1, 2021 to March 31, 2021.
As of March 31, 2021, Thomas Videbæk has stepped down as director of NOVOZYMES A/S.
NOVOZYMES A/S has published its annual report for 2020. Revenue came to DKK 14,012,000,000, and the net result was DKK 2,826,000,000.
As of March 11, 2021, Anne Elme Breum has joined the board of directors of NOVOZYMES A/S.
As of March 11, 2021, Lena Bech Holskov has joined the board of directors of NOVOZYMES A/S.
As of March 11, 2021, Preben Nielsen has joined the board of directors of NOVOZYMES A/S.
As of March 11, 2021, Jens Øbro has joined the board of directors of NOVOZYMES A/S.
As of March 11, 2021, Jannik Bo Riis has joined the board of directors of NOVOZYMES A/S.
About NOVOZYMES A/S
NOVOZYMES A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 2000. The company is registered under the industry Fremstilling af andre organiske basiskemikalier. The management consists of Ester Baiget Arnau and Rainer Chapour Lehmann. The board consists of Cornelis de Jong (chair), Heine Dalsgaard, Frederikke Rose Spenner and Kasim Kutay. The company is owned by Novo Holdings A/S and BlackRock, Inc.. The company has 3,508 employees (2026). In 2025, the company reported revenue of EUR 4,157,600,000 and a net result of EUR 583,600,000 compared with EUR 305,800,000 the year before. Equity in the 2025 report amounted to EUR 10,855,200,000.